Hepatitis C drugs boost Remdesivir’s antiviral activity against COVID-19
Credit: Illustration credit: Jenna Luecke/University of Texas at Austin. Remdesivir is currently the only antiviral drug approved in the U.S. for treating COVID-19 patients. In...
















